Article Dans Une Revue Multiple Sclerosis and Related Disorders Année : 2023

Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study

Fichier non déposé

Dates et versions

hal-04456656 , version 1 (14-02-2024)

Identifiants

Citer

Maya Zeineddine, Raed Al-Roughani, Samia Khoury, Nabil El-Ayoubi, Akram Al-Mahdawi, et al.. Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study. Multiple Sclerosis and Related Disorders, 2023, 80, pp.105299. ⟨10.1016/j.msard.2023.105299⟩. ⟨hal-04456656⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

More